AAAAAA

   
Results: 1-22 |
Results: 22
Percutaneous pulmonary artery and vein stenting - A novel treatment for mediastinal fibrosis
Authors: Doyle, TP Loyd, JE Robbins, IM
Citation: Tp. Doyle et al., Percutaneous pulmonary artery and vein stenting - A novel treatment for mediastinal fibrosis, AM J R CRIT, 164(4), 2001, pp. 657-660
RAD in stable lung and heart/lung transplant recipients: Safety, tolerability, pharmacokinetics, and impact of cystic fibrosis
Authors: Doyle, RL Hertz, MI Dunitz, JM Loyd, JE Stecenko, AA Wong, RL Chappell, KA Brazelton, T Kovarik, JM Appeldingmanse, S Dou, L Smith, HT Tudor, D Morris, RE
Citation: Rl. Doyle et al., RAD in stable lung and heart/lung transplant recipients: Safety, tolerability, pharmacokinetics, and impact of cystic fibrosis, J HEART LUN, 20(3), 2001, pp. 330-339
Mutation in the gene for bone morphogenetic protein receptor II as a causeof primary pulmonary hypertension in a large kindred
Authors: Newman, JH Wheeler, L Lane, KB Loyd, E Gaddipati, R Phillips, JA Loyd, JE
Citation: Jh. Newman et al., Mutation in the gene for bone morphogenetic protein receptor II as a causeof primary pulmonary hypertension in a large kindred, N ENG J MED, 345(5), 2001, pp. 319-324
Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia
Authors: Trembath, RC Thomson, JR Machado, RD Morgan, NV Atkinson, C Winship, I Simonneau, G Galie, N Loyd, JE Humbert, M Nichols, WC Morrell, NW Berg, J Manes, A McGaughran, J Pauciulo, M Wheeler, L
Citation: Rc. Trembath et al., Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia, N ENG J MED, 345(5), 2001, pp. 325-334
Pulmonary artery stenosis and fibrous mediastinitis
Authors: Robbins, IM Davis, AM Doyle, TP Loyd, JE
Citation: Im. Robbins et al., Pulmonary artery stenosis and fibrous mediastinitis, CHEST, 120(5), 2001, pp. 1750-1751
Lung biopsy in pulmonary veno-occlusive disease
Authors: Robbins, II Holcomb, BV Loyd, JE
Citation: Ii. Robbins et al., Lung biopsy in pulmonary veno-occlusive disease, CHEST, 120(4), 2001, pp. 1421-1422
Regulation of CCAAT/enhancer-binding protein-beta is altered in primary lung fibroblasts obtained from patients with idiopathic pulmonary fibrosis
Authors: Cruz-Gervis, RA Stecenko, AA Blackwell, TS Sealy, L Loyd, JE King, G Brigham, KL
Citation: Ra. Cruz-gervis et al., Regulation of CCAAT/enhancer-binding protein-beta is altered in primary lung fibroblasts obtained from patients with idiopathic pulmonary fibrosis, CHEST, 120(1), 2001, pp. 9S-9S
Idiopathic pulmonary fibrosis can be an autosomal dominant trait in some families
Authors: Marney, A Lane, KB Phillips, JA Riley, DJ Loyd, JE
Citation: A. Marney et al., Idiopathic pulmonary fibrosis can be an autosomal dominant trait in some families, CHEST, 120(1), 2001, pp. 56S-56S
Is vasculitis an early pathogenic mechanism of interstitial pulmonary fibrosis?
Authors: Davis, AM Johnson, JE Cruz-Gervis, R Marney, A Tang, YW Loyd, JE Peebles, RS
Citation: Am. Davis et al., Is vasculitis an early pathogenic mechanism of interstitial pulmonary fibrosis?, CHEST, 120(1), 2001, pp. 57S-57S
Iatrogenic paradoxical air embolism in pulmonary hypertension
Authors: Holcomb, BW Loyd, JE Byrd, BF Wilsdorf, TT Casey-Cato, T Mason, WR Robbins, IM
Citation: Bw. Holcomb et al., Iatrogenic paradoxical air embolism in pulmonary hypertension, CHEST, 119(5), 2001, pp. 1602-1605
Gene expression patterns in the lungs of patients with primary pulmonary hypertension - A gene microarray analysis
Authors: Geraci, MW Moore, M Gesell, T Yeager, ME Alger, L Golpon, H Gao, BF Loyd, JE Tuder, RM Voelkel, NF
Citation: Mw. Geraci et al., Gene expression patterns in the lungs of patients with primary pulmonary hypertension - A gene microarray analysis, CIRCUL RES, 88(6), 2001, pp. 555-562
BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension
Authors: Machado, RD Pauciulo, MW Thomson, JR Lane, KB Morgan, NV Wheeler, L Phillips, JA Newman, J Williams, D Galie, N Manes, A McNeil, K Yacoub, M Mikhail, G Rogers, P Corris, P Humbert, M Donnai, D Martensson, G Tranebjaerg, L Loyd, JE Trembath, RC Nichols, WC
Citation: Rd. Machado et al., BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension, AM J HU GEN, 68(1), 2001, pp. 92-102
Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension
Authors: Lane, KB Machado, RD Pauciulo, MW Thomson, JR Phillips, JA Loyd, JE Nichols, WC Trembath, RC
Citation: Kb. Lane et al., Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension, NAT GENET, 26(1), 2000, pp. 81-84
Lung allocation in the United States, 1995-1997: An analysis of equity andutility
Authors: Pierson, RN Milstone, AP Loyd, JE Lewis, BH Pinson, CW Ely, EW
Citation: Rn. Pierson et al., Lung allocation in the United States, 1995-1997: An analysis of equity andutility, J HEART LUN, 19(9), 2000, pp. 846-851
Active CMV infection before lung transplantation: Risk factors and clinical implications
Authors: Milstone, AP Brumble, LM Loyd, JE Ely, EW Roberts, JR Pierson, RN Dummer, JS
Citation: Ap. Milstone et al., Active CMV infection before lung transplantation: Risk factors and clinical implications, J HEART LUN, 19(8), 2000, pp. 744-750
Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family
Authors: Thomson, JR Machado, RD Pauciulo, MW Morgan, NV Humbert, M Elliott, GC Ward, K Yacoub, M Mikhail, G Rogers, P Newman, J Wheeler, L Higenbottam, T Gibbs, JSR Egan, J Crozier, A Peacock, A Allcock, R Corris, P Loyd, JE Trembath, RC Nichols, WC
Citation: Jr. Thomson et al., Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family, J MED GENET, 37(10), 2000, pp. 741-745
Pulmonary veno-occlusive disease - A case series and new observations
Authors: Holcomb, BW Loyd, JE Ely, EW Johnson, J Robbins, IM
Citation: Bw. Holcomb et al., Pulmonary veno-occlusive disease - A case series and new observations, CHEST, 118(6), 2000, pp. 1671-1679
Mediastinal fibrosis is associated with human leukocyte antigen-A2
Authors: Peebles, RS Carpenter, CT Dupont, WD Loyd, JE
Citation: Rs. Peebles et al., Mediastinal fibrosis is associated with human leukocyte antigen-A2, CHEST, 117(2), 2000, pp. 482-485
Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus
Authors: Robbins, IM Gaine, SP Schilz, R Tapson, VF Rubin, LJ Loyd, JE
Citation: Im. Robbins et al., Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus, CHEST, 117(1), 2000, pp. 14-18
Respiratory bronchiolitis associated with severe dyspnea, exertional hypoxemia, and clubbing
Authors: Sadikot, RT Johnson, J Loyd, JE Christman, JW
Citation: Rt. Sadikot et al., Respiratory bronchiolitis associated with severe dyspnea, exertional hypoxemia, and clubbing, CHEST, 117(1), 2000, pp. 282-285
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease - A randomized, controlled trial
Authors: Badesch, DB Tapson, VF McGoon, MD Brundage, BH Rubin, LJ Wigley, FM Rich, S Barst, RJ Barrett, PS Kral, KM Jobsis, MM Loyd, JE Murali, S Frost, A Girgis, R Bourge, RC Ralph, DD Elliott, CG Hill, NS Langleben, D Schilz, RJ McLaughlin, VV Robbins, IM Groves, BM Shapiro, S Medsger, TA Gaine, SP Horn, E Decker, JC Knobil, K
Citation: Db. Badesch et al., Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease - A randomized, controlled trial, ANN INT MED, 132(6), 2000, pp. 425
Quantitative 3D VUSE pulmonary MRA
Authors: Friedli, JL Paschal, CB Loyd, JE Halliburton, SS
Citation: Jl. Friedli et al., Quantitative 3D VUSE pulmonary MRA, MAGN RES IM, 17(3), 1999, pp. 363-370
Risultati: 1-22 |